Community Engagement and Ethical Practice in Vaccine Research. (360G-Wellcome-087667_Z_08_Z)

KEMRI/CDC is involved in a multi-site phase III infant vaccine study aimed at evaluating the efficacy of an oral Rotavirus vaccine in African and Asian populations. At the KEMRI/CDC field station 1000 participants have been recruited from five rural clinics in Karemo Division in western Kenya. This is the first vaccine trial KEMRI/CDC has conducted, and the first clinical trial in this division. Preparations included community consultations, stakeholder meetings and the establishment of a commu nity advisory board. Vaccine research will continue in Karemo with a Malaria infant vaccine efficacy trial scheduled to start in January 2009 and future Tuberculosis vaccine studies planned. These studies present an important opportunity to observe and document how the field research station engages with the community, and consider how these strategies and activities support ethical practice. Participant observation, which is central to an ethnographic approach, will allow researchers gain insi ghts into the context, while semi-structured interviews and focus groups will provide the opportunity to explore the perspectives of field station staff, community members and representatives, as well as parents of participants. The results will provide a critical analysis of the practice of community engagement, which has been described as a benchmark of ethical research (1).

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 30584
Applicant Surname Geissler
Approval Committee Biomedical Ethics Funding Committee
Award Date 2009-02-18T00:00:00+00:00
Financial Year 2008/09
Grant Programme: Title Project funding: Inactive scheme
Internal ID 087667/Z/08/Z
Lead Applicant Prof Paul Geissler
Other Applicant(s) Dr John Vulule, Ms Tracey Chantler
Partnership Value 30584
Planned Dates: End Date 2011-04-30T00:00:00+00:00
Planned Dates: Start Date 2009-04-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London